Funder
National Institutes of Health
Reference9 articles.
1. on behalf of the Healthy Livers, Healthy Lives Collaborators. A global action agenda for turning the tide on fatty liver disease;Lazarus;Hepatology,2024
2. Resmetirom’s approval: highlighting the need for comprehensive approaches in NASH therapeutics;Alshehade;Clin Res Hepatol Gastroenterol,2024
3. Prevalence of steatotic liver disease subtypes and association with metabolic risk factors in the Framingham Heart Study;Sun;Clin Gastroenterol Hepatol,2024
4. Hepatocellular RECK as a critical regulator of metabolic dysfunction-associated steatohepatitis development;Dashek;Cell Mol Gastroenterol Hepatol,2024
5. Reversion inducing cysteine rich protein with Kazal motifs and cardiovascular diseases: the RECKlessness of adverse remodeling;Russell;Cellular Signalling,2021